DIVES MED AMI 200

DIVES MED AMI 200

DIVES MED AMI 200 is an advanced professional tissue stimulator developed for treatment programmes focused on skin firmness, elasticity, structural quality and visible signs of ageing.

The formulation combines fragmented hyaluronic acid (HAF) with six amino acids and choline, creating a multi-component approach to professional skin rejuvenation.

Rather than positioning hyaluronic acid solely around hydration, AMI 200 uses fragmented HA as part of a broader tissue-stimulation concept focused on the extracellular matrix, fibroblast activity and progressive improvement in skin quality.

HAF – HYALURONIC ACID FRAGMENTS

At the centre of AMI 200 is DIVES MED's HAF technology.

The fragmented hyaluronic acid consists of 20–38 monomers. DIVES describes these low-molecular-weight fragments as interacting with CD44 receptors on fibroblasts and supporting processes associated with extracellular matrix remodelling and collagen, elastin and glycosaminoglycan synthesis.

This gives AMI 200 a different treatment concept from conventional hydration-focused HA products.

SIX-AMINO-ACID COMPLEX

AMI 200 combines HAF with six amino acids:

Serine | Alanine | Cysteine | Lysine | Proline | Glycine

These amino acids complement the fragmented HA technology within a formulation designed around tissue quality, regeneration and structural skin support.

CHOLINE

AMI 200 also contains choline, an important differentiating component of the formulation.

DIVES describes choline as a precursor of acetylcholine and positions it within AMI 200 around processes associated with muscle tone, epidermal function and maintenance of facial contours.

Although choline is important technically, we've deliberately kept it out of the product title so the website uses the shorter and more recognisable DIVES MED AMI 200 name.

FIRMNESS & STRUCTURAL REJUVENATION

AMI 200 is particularly relevant where the treatment objective extends beyond superficial hydration.

The formulation can form part of practitioner-led programmes addressing reduced firmness, skin laxity, wrinkles, reduced elasticity and deteriorating structural skin quality.

This gives AMI 200 a clear position within regenerative and age-management treatment planning.

FACIAL AGE-MANAGEMENT

Progressive ageing involves changes across multiple levels of facial tissue. Skin can become thinner, less elastic and less firm while visible wrinkles and changes in facial contours become increasingly apparent.

AMI 200 provides practitioners with an option for treatment strategies focused on progressive skin-quality improvement and tissue stimulation rather than conventional volumisation alone.